Eclosix has acquired the exclusive UK distribution rights from Orexigen Therapeutics Ireland for Mysimba, a proprietary combination of prolonged release naltrexone and bupropion.
AMADA WELD TECH highlights its ability to strategically partner with manufacturers using hot bar bonding by integrating application engineering expertise, custom thermode design, and scalable equipment platforms into a unified solution.
The Hosokawa Micron Group will be presenting its 360-degree service portfolio for powder and bulk material processing at Powtech TechnoPharm 2026, taking place from 29th September to 1st October at the Nuremberg Exhibition Centre, Hall 7a, Stand 530.
CPHI Milan 2026 has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the future of healthcare manufacturing and supply chains.
A new survey reveals widespread concern among respondents about counterfeit medication, with six in 10 worried their prescribed drugs might be fake or substandard.
Alfa Laval UK & Ireland has appointed Alessandro Bracco as its new managing director, as part of a targeted push for growth in a number of key strategic sectors, including pharmaceutical.
IMCD Group, a global partner for the distribution and formulation of speciality chemicals and ingredients, has opened its new Pharmaceutical Technical Centre and Food & Nutrition US Technical Hub in IMCD’s new offices in Allendale, New Jersey, USA.
Thomas Halfmann, smart factory advisor at eschbach, and Andreas Eschbach, CEO and founder of Eschbach, outline five steps manufacturers can take to break down these barriers and realise the vision of the adaptive plant.
Russelectric a manufacturer of power control systems and automatic transfer switches, introduces its new ATS Remote Annunciator (RTS-RA), a powerful accessory that brings together data from multiple Automatic Transfer Switches into a single display.
Circio Holding and Tcelltech has announced a research collaboration to combine Circio's circVec circular RNA expression technology with Tcelltech's non-integrating nanoSMAR vector platform for the development of next gen engineered T-cell therapies.
